6-K

AURINIA PHARMACEUTICALS INC. 6-K

Company: Aurinia Pharmaceuticals Inc.
Filed: December 21, 2020
Period of Report: December 17, 2020
Accession Number: 0001157523-20-001616

View Document ↗ View on SEC.gov ↗